Thermo Fisher Posts 4 Percent Increase in Q2 Revenues | GenomeWeb

The story has been updated to include comments from company officials from its earnings conference call.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that its second quarter revenues improved 4 percent year over year, as the company exceeded the average analyst estimates on the top and bottom lines.

Companywide revenues for the three months ended June 29 reached $3.24 billion, up from $3.11 billion a year ago, beating the consensus Wall Street estimate of $3.22 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions. is eyeing an expansion into genomic risk assessments, the Verge reports.